Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Prepaid Assets (2020 - 2025)

Mereo BioPharma (MREO) has disclosed Prepaid Assets for 6 consecutive years, with $2.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 29.66% to $2.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.7 million, a 29.66% decrease, with the full-year FY2024 number at $2.2 million, up 539.71% from a year prior.
  • Prepaid Assets was $2.7 million for Q3 2025 at Mereo BioPharma, up from $2.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.4 million in Q4 2022 to a low of $340000.0 in Q4 2023.
  • A 5-year average of $2.9 million and a median of $2.7 million in 2025 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: plummeted 93.76% in 2023, then soared 539.71% in 2024.
  • Mereo BioPharma's Prepaid Assets stood at $3.8 million in 2021, then surged by 44.34% to $5.4 million in 2022, then tumbled by 93.76% to $340000.0 in 2023, then skyrocketed by 539.71% to $2.2 million in 2024, then increased by 23.86% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for MREO's Prepaid Assets are $2.7 million (Q3 2025), $2.5 million (Q2 2025), and $2.5 million (Q1 2025).